Ionis Pharmaceuticals, Inc. (IONS) has a market capitalization of $12.68B and trades at $76.76. The 52-week range is 23.95-86.74.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -32.3, Earnings Per Share (EPS) of $-2.38, annual revenue of $944M.
The stock has a beta of 0.40, operates in the Healthcare sector.
